Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fobi AI Inc V.FOBI

Alternate Symbol(s):  FOBIF

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the technology industry and sells software as a service (SaaS), reselling, referring, and licensing its technology to licensors. The Company enables businesses to action, leverage, and monetize their customer data by powering personalized and data-driven customer experiences. The Company provides solutions, such as data, wallet passes, coupon platform, and marketing services. Its Sunflora is a global health and wellness retailer in the United States. Its wallet pass platforms deliver personalized, digital experiences directly through the mobile wallet. Wallet apps are used to save digital passes like coupons, membership cards, and event tickets as well as means of payment like credit cards. Its marketing services offer copywriting, blog post writing, video production, podcast production, photo editing, and more. It also offers a Qples SaaS coupon management platform.


TSXV:FOBI - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Fjordkrone22on Jan 27, 2021 3:06pm
229 Views
Post# 32401226

A Potential game-changer ! Green Leaf!

A Potential game-changer ! Green Leaf!
Sponsored Post
 
 
Some of these other companies new laboratory could potentially produce an approx. 2.9 million inhalers and other products per year.  In addition, as the possible demand elevated, some of these other companies could scale to double the output with minimal additional personnel or potential capital outlay in about 9-12 weeks.
 
It was stated that these other companies could possibly produce other aerosolized products in the future such as prescription and medication. Meanwhile, these other companies claim that any isolate not consumed in its primary products will be marketed as medical or pharmaceutical grade isolate directly in the health and wellness market.
 
Check the disclaimer on profile and landing page.
 
<< Previous
Bullboard Posts
Next >>